氟-18脱氧葡萄糖正电子发射断层扫描/磁共振成像(18F-FDG PET/MRI)在肺癌分期中定性胸腔积液和检测胸膜转移的价值
研究纳入29例原发性肺部肿块患者,于2021年6月至2023年6月行3-T PET/MRI,评估SUVmax、T2FS信号、ADC和DWI信号在鉴别炎性与肿瘤相关胸腔积液的效能,敏感度分别为78.95%、94.74%、68.42%、84.21%,特异度分别为100%、50%、80%、100%,准确率分别为86.21%、79.31%、72.41%、89.66%。作者结论认为18F-FDG PET/MRI在定性胸腔积液和检测恶性胸膜受累方面诊断性能高,且在识别胸膜转移方面诊断性能高于PET/CT。
要点
- DWI信号鉴别肿瘤相关胸腔积液的敏感度84.21%、特异度100%、准确率89.66%。
- T2FS信号敏感度最高(94.74%),但特异度仅50%。
- SUVmax特异度100%、准确率86.21%,ADC准确率72.41%。
核心结论
- 18F-FDG PET/MRI在定性胸腔积液和检测恶性胸膜受累方面诊断性能高。
- 作者指出18F-FDG PET/MRI识别肺癌合并胸腔积液患者胸膜转移的诊断性能高于PET/CT。
研究设计与样本
- 单中心研究,纳入29例原发性肺部肿块患者,时间为2021年6月至2023年6月。
- 采用3-T混合PET/MRI,序列包括轴位呼吸触发快速自旋回波T2加权成像、轴位呼吸触发T2脂肪抑制序列,以及b值为50和800 sec/mm2的回波平面成像扩散加权成像。
- 由经验丰富的医师通过MRI序列视觉评估T2FS上胸腔积液信号及DWI上胸膜局限性高信号,并在PET图像上测量所有病变(包括原发肺部病变和胸腔积液)的SUVmax。
关键影像表现/征象
- 在T2FS上评估胸腔积液的信号,并在DWI序列上评估胸膜局限性高信号。
- 在PET图像上测量所有病变(包括原发肺部病变和胸腔积液)的SUVmax。
诊断标准与关键数值
- SUVmax鉴别炎性与肿瘤相关胸腔积液的敏感度78.95%、特异度100%、准确率86.21%。
- T2FS信号鉴别炎性与肿瘤相关胸腔积液的敏感度94.74%、特异度50%、准确率79.31%。
- ADC鉴别炎性与肿瘤相关胸腔积液的敏感度68.42%、特异度80%、准确率72.41%。
- DWI信号鉴别炎性与肿瘤相关胸腔积液的敏感度84.21%、特异度100%、准确率89.66%。
临床应用与阅片要点
- 可综合SUVmax、T2FS信号、ADC和DWI信号评估胸腔积液性质及胸膜受累情况。
- DWI信号与SUVmax特异度均为100%,T2FS信号敏感度最高但特异度仅50%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: Positron emission tomography/magnetic resonance imaging (PET/MRI) combines the anatomical imaging of MRI with the metabolic information of PET. This study aimed to investigate the diagnostic value of PET/MRI in characterising pleural effusions and detecting pleural nodules, which is critical for staging and management in patients with primary pulmonary masses.
MATERIALS AND METHODS: A total of 29 patients were enrolled in the study from June 2021 to June 2023. A 3-T hybrid PET/MRI including axial respiratory-triggered fast-spin echo T2-weighted imaging (T2WI), axial respiratory triggered T2 fat-suppressing sequence (T2FS), and echo-planar imaging diffusion-weighted imaging (DWI) with b values of 50 and 800 sec/mm2. The maximum standardised uptake value (SUVmax) for all lesions (including primary lung lesions and pleural effusion) was measured on PET images. The signal of pleural effusion on T2FS and localised high signals of the pleura on DWI sequences were evaluated by experienced physicians through visual assessment of the MRI sequences.
RESULTS: SUVmax, T2FS signal, apparent diffusion coefficient (ADC), and DWI signal exhibit significant differences between inflammatory lesions and tumour-related pleural effusions, with sensitivities of 78.95%, 94.74%, 68.42%, and 84.21%, respectively; specificities of 100%, 50%, 80%, and 100%, respectively; and accuracies of 86.21%, 79.31%, 72.41%, and 89.66%, respectively.
CONCLUSION: Fluorine-18 fluorodeoxyglucose (18F-FDG) PET/MRI demonstrates high diagnostic performance in characterising pleural effusions and detecting malignant pleural involvement. Moreover, 18F-FDG PET/MRI showed a higher diagnostic performance compared with PET/CT in identifying pleural metastases for staging lung cancer combined with pleural effusion.
引用
- Zhang A, Kong X, Yao Y, et al. The value of fluorine-18 fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI) in characterising pleural effusion and detecting pleural metastasis for staging lung cancer. Clin Radiol. 2025. PMID: 41863190. doi:10.1016/j.crad.2025.107194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。